Observational analysis identified survival outcomes and toxic side effects in patients with esophageal cancer, suggesting important correlations with prognosis.
Key Points
Recurrence and local control failure were the main causes of mortality, emphasizing the need for early diagnosis.
Overall survival rates were 82.3%, 50.9%, and 40.0% at 1, 2, and 4 years, respectively, indicating the treatment's effectiveness.
Shorter tumor length and early clinical stage were significant independent prognostic factors linked to better survival outcomes.
This study provides insights for optimizing concurrent chemoradiotherapy strategies to improve patient quality of life.